The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

New technologies to replace current blood typing reagents.

På svenska

Author

Summary, in English

Purpose of review This review summarizes recent developments in blood grouping and compatibility testing in transfusion medicine. Recent findings Identification of the molecular characteristics of the major human blood groups has provided an opportunity to develop methods for blood group phenotyping using DNA-based technology. Various studies have demonstrated the feasibility of such an approach and have demonstrated the potential to change current procedures for identifying compatible blood, both in routine settings and in highly immunized patients, for whom compatible blood is difficult to obtain. In the obstetric setting, isolation of cell-free DNA from maternal plasma for fetal blood grouping provides a minimally invasive method for determining the risk for haemolytic disease in the newborn. Recombinant technology for synthesizing blood group proteins, although in its infancy, has the potential to change longstanding antibody identification procedures. Summary The molecular revolution occurring throughout medicine is broadly manifest in all areas of transfusion medicine and should contribute to transfusion safety.

Publishing year

2007

Language

English

Pages

677-681

Publication/Series

Current Opinion in Hematology

Volume

14

Issue

6

Document type

Journal article

Publisher

Lippincott Williams & Wilkins

Topic

  • Hematology

Keywords

  • microarray
  • DNA analysis
  • blood groups

Status

Published

ISBN/ISSN/Other

  • ISSN: 1531-7048